Track topics on Twitter Track topics that are important to you
EpicGenetics and Massachusetts General Hospital (MGH) are launching a Phase II clinical trial to test a tuberculosis vaccine, CBG, as a potential treatment for fibromyalgia.
EpicGenetics, the biomedical company that developed and offers the FM/a Test, the FDA-compliant diagnostic blood test that identifies the immune system biomarkers of fibrom...
The biomedical company addresses requirements in response to surge of inquiries Last month, EpicGenetics announced that the U.S. Food and Drug Administration (FDA) has ...
FM/a Test provides an objective diagnosis to determine if child can avoid unnecessary medications for ADHD After analyzing thousands of patients, EpicGenetics today announced ...
The trial will analyze the impact of bacillus Calmette-Guerin (BCG) on the disease Today EpicGenetics announced that the U.S. Food and Drug Administration (FDA) has giv...
Based in Santa Monica, Calif., EpicGenetics (www.epicgtx.com) was founded in 2010 by Bruce S. Gillis, MD, MPH, as a privately-held biomedical company, dedicated to developing conc...
We have published hundreds of EpicGenetics news stories on BioPortfolio along with dozens of EpicGenetics Clinical Trials and PubMed Articles about EpicGenetics for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of EpicGenetics Companies in our database. You can also find out about relevant EpicGenetics Drugs and Medications on this site too.